Business Standard

Oxford University Covid-19 vaccine raises hopes with strong trial results

Blood samples taken from a group of UK volunteers given a dose of the vaccine showed that it stimulated the body to produce both antibodies and killer T-cells

covid, coronavirus, vaccine, drug, pharma
Premium

The vaccine development, by the university's Jenner Institute, is being supported by the UK government and AstraZeneca

Press Trust of India London
Researchers at the University of Oxford believe they may have a breakthrough in their search for a Covid-19 vaccine after the team discovered that the jab could provide "double protection" against the deadly coronavirus following early stage human trials, according to media reports in the UK.

Blood samples taken from a group of UK volunteers given a dose of the vaccine showed that it stimulated the body to produce both antibodies and killer T-cells, a senior source from the trial was quoted by The Daily Telegraph' as saying.

The discovery is promising because separate studies have suggested that antibodies may

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in